Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 13, 2017 11:48 ET | Source: Trek Therapeutics

Trek Therapeutics Announces Oral Presentation of Faldaprevir, TD-6450 and Ribavirin Ph2a Trial Results at the Asian Pacific Association for the Study of the Liver on February 18, 2017 in Shanghai

CAMBRIDGE, Mass., Feb. 13, 2017 (GLOBE NEWSWIRE) -- Trek Therapeutics, PBC announced today that results from an ongoing Phase (Ph) 2a clinical trial to evaluate all-oral combination regimens to...